Market Overview - The Hang Seng Index rose by 0.44%, gaining 113 points to close at 25,749 points, while the Hang Seng Tech Index increased by 1.04%. The morning trading volume reached 96.5 billion HKD [1]. New Listings - Six new stocks were listed on the Hong Kong Stock Exchange with mixed performance: - Inspur Intelligent (03696) surged over 34% - Meilian Holdings (02671) rose by 30% - Xunce (03317) briefly fell below issue price, down 0.08% - Woan Robotics (06600) remained unchanged - Linqingxuan (02657) increased by over 14% - Wuyi Vision (06651) gained over 18% [1]. Notable Stocks - Baidu Group-SW (09888) led blue-chip stocks with a 6.8% increase, driven by its expansion into the UK with autonomous vehicles and the anticipated ramp-up of its self-developed AI chip, Kunlun [1]. - Liqin Resources (02245) also saw a rise of over 6%, influenced by policy disruptions in the nickel market in Indonesia, with its pyrometallurgical project expected to be fully operational by 2026 [1]. Collaborations and Innovations - Maifushi (02556) experienced a surge of over 10% due to deep collaborations with Baidu and other tech companies, marking a potential turning point for AI Agent adoption [2]. - InnoScience (02577) rose by over 9%, with its gallium nitride products meeting core demands across multiple sectors [3]. - Zhongwei New Materials (02579) increased by nearly 7% after signing a strategic cooperation framework agreement with Xinwanda (300207) to jointly develop new precursor materials for solid-state batteries [3]. - Asia Pacific Satellite (01045) rose by 5%, operating multiple satellites including Asia Pacific 5C as a subsidiary of China Satcom (601698) [3]. Clinical Developments - Tongyuan Kang Pharmaceutical-B (02410) saw an increase of over 2% as it initiated Phase I/II clinical trials for the TYK-01054 capsule, targeting advanced solid tumors [4]. Shareholder Actions - Zhaoyan New Drug (603127) (06127) fell by over 6% as its controlling shareholder plans to reduce holdings by up to 14.98 million A-shares [5].

Group 1 - Zijin Mining (02899) rose nearly 3% after announcing the completion of the main construction and core equipment installation for the second phase of the Xizang Julong Copper Mine, marking a key step before production [1] - Asia Pacific Satellite (01045) increased over 5.4%, with a cumulative rise of nearly 30% over the past five trading days, as it operates multiple satellites under China Satcom [1] - Zhaoyan New Drug (06127) fell over 6% following an announcement that its actual controller plans to reduce holdings by up to 14.98 million shares, representing 20.0466% of his holdings and 1.99873% of the company's total share capital [1] - Zhongwei New Materials (02579) surged nearly 7% after signing a strategic cooperation framework agreement with Xinwanda for solid-state batteries [1] Group 2 - Dongyue Group (00189) rose nearly 5% as the long-term contract prices for refrigerants were confirmed, with R32 priced at 61,200 yuan/ton (+1,000 yuan) and R410A at 55,100 yuan/ton (+1,900 yuan) [2] - MicroPort Scientific Corporation (02252) increased over 1.2%, reporting that its core products' cumulative order volume exceeded 230 units [2] - Oil stocks saw gains, with CNOOC (00883) up 4.17%, PetroChina (00857) up 2.91%, and Sinopec (00386) up 1.31%, driven by a rise in international crude oil prices due to geopolitical tensions [2] - Baidu Group (09888) rose nearly 7% after announcing a partnership with Uber and Lyft to launch a robotaxi pilot project in the UK by 2026 [2] Group 3 - NIO (09866) rose over 2.4% after announcing that it successfully delivered over 40,000 units of its new ES8 model within 100 days of the official delivery start [3] - Damai Entertainment (01060) increased nearly 5%, with the total box office for the 2025 New Year’s season reaching 5.245 billion yuan as of December 28 [3] Group 4 - Copper mining stocks collectively declined, with Hudbay Minerals (HBM.US) down 4.01%, Taseko Mines (TGB.US) down 3.1%, and Ero Copper (ERO.US) down 1.64%, as international copper futures fell over 4% [5] - Some cryptocurrency-related stocks fell, with IREN Ltd (IREN.US) down 2.21% and Circle (CRCL.US) down 0.94% [5] - NIO (NIO.US) rose 4.71% in the US market, echoing its performance in Hong Kong [6] - The Nasdaq Golden Dragon Index fell nearly 1%, with major Chinese concept stocks declining, including Alibaba (BABA.US) down 2.46% and Xpeng Motors (XPEV.US) down 1.35% [6]

智通财经APP获悉，港股恒生指数涨0.44%，涨113点，报25749点；恒生科技指数涨1.04%。港股早盘成 交965亿港元。 6只新股在港交所挂牌上市，涨跌不一。英矽智能（03696）涨超34%；美联股份（02671）涨30%；迅 策（03317）一度破发跌0.08%；卧安机器人（06600）无涨跌；林清轩（02657）涨超14%；五一视界 （06651）涨超18%。 百度集团-SW(09888)涨6.8%领涨蓝筹，百度无人车布局英国，自研AI芯片昆仑芯有望进入放量期。 同源康医药-B(02410)现涨超2%，TYK-01054胶囊启动I/II期临床，适应症为晚期实体瘤。 昭衍新药(06127)跌超6%，实控人拟减持不超1498万股A股股份。 英诺赛科(02577)涨超9%，公司氮化镓产品精准契合多领域核心需求。 中伟新材(02579)涨近7%，与欣旺达签署固态电池战略合作框架协议，联合开发新型正极材料前驱体。 亚太卫星(01045)再涨5%，公司为中国卫通控股子公司，当前运营亚太5C等多颗卫星。 力勤资源(02245)再涨超6%，印尼政策扰动镍市，公司火法项目2026年全部投产。 迈富时(02556)涨 ...

每经AI快讯，昭衍新药(06127.HK)跌超6%，截至发稿跌6.25%，报19.8港元，成交额8459.44万港元。 （文章来源：每日经济新闻） ...

智通财经APP获悉，昭衍新药(06127)跌超6%，截至发稿，跌6.25%，报19.8港元，成交额8459.44万港 元。 消息面上，12月29日，昭衍新药发公告称，公司实际控制人之一周志文拟自减持计划公告之日起15个交 易日后的3个月内通过集中竞价或大宗交易的方式减持不超过1498万股，不超过其持有股份的 20.0466%，不超过公司总股本的1.99873%。截至该公告披露日，周志文持有昭衍新药股票7472.6万股， 占公司总股本的9.9704%，股份来源于IPO前取得及公司资本公积金转增，减持原因为自身资金需求。 ...

昭衍新药（603127）(06127)跌超6%，截至发稿，跌6.25%，报19.8港元，成交额8459.44万港元。 消息面上，12月29日，昭衍新药发公告称，公司实际控制人之一周志文拟自减持计划公告之日起15个交 易日后的3个月内通过集中竞价或大宗交易的方式减持不超过1498万股，不超过其持有股份的 20.0466%，不超过公司总股本的1.99873%。截至该公告披露日，周志文持有昭衍新药股票7472.6万股， 占公司总股本的9.9704%，股份来源于IPO前取得及公司资本公积金转增，减持原因为自身资金需求。 ...

Market Overview - The U.S. stock market saw slight declines with the Dow Jones down 0.51%, Nasdaq down 0.5%, and S&P 500 down 0.35%. Major tech stocks mostly fell, with Tesla down over 3% and Nvidia down over 1%. Intel rose over 1%, while Apple and Google saw slight increases. The Nasdaq Golden Dragon China Index fell 0.67%, with most Chinese concept stocks declining [1] - European stock indices had mixed results, with Germany's DAX up 0.05%, France's CAC40 up 0.1%, and the UK's FTSE 100 down 0.04%. International oil prices rose significantly, with U.S. oil up 2.01% at $57.87 per barrel and Brent crude up 1.96% at $61.42 per barrel. Gold and silver prices fell sharply, with spot gold down over $200, a decline of 4.36% [2] Industry Insights - China's private rocket company "New Space Aerospace" announced the launch of key technology tests for the recovery and reuse of the Chitu-1 rocket, indicating progress in low-cost, high-reliability space technology. The Shanghai Stock Exchange has provided clearer pathways for commercial rocket companies to list on the Sci-Tech Innovation Board [3] - The satellite internet sector is expected to become a new industrial field, with the satellite communication industry projected to exceed 200 billion to 400 billion yuan by 2030, with an annual compound growth rate of 10%-28%. This sector is transitioning from concept validation to large-scale application, becoming a key driver for high-quality digital economic development [4] - The People's Bank of China released an action plan to strengthen the management and service system for digital RMB, with a new framework set to be implemented by January 1, 2026. As of November 2025, digital RMB transactions reached 34.8 billion, totaling 16.7 trillion yuan [5] - The digital RMB cross-border payment system is expected to connect with ASEAN and Middle Eastern countries, potentially allowing 38% of global trade to bypass the SWIFT system. The central bank's digital currency bridge model facilitates cross-border payments without intermediary banks [6] - Dongguan Jimu Machinery Co., Ltd. increased its registered capital from 3.89 billion yuan to approximately 4.689 billion yuan, a rise of about 21%. This company, fully owned by Huawei, is expected to play a significant role in the humanoid robot industry [7] - The humanoid robot industry is anticipated to enter a critical growth phase in 2025, driven by advancements in component performance and cost reduction. The domestic market is expected to see significant growth in robot shipments, with key beneficiaries in core supply chains and application scenarios [8]

Group 1: Regulatory Developments - The National Medical Products Administration (NMPA) held a meeting to summarize the regulatory achievements of 2025 and discuss key work for 2026, emphasizing the need for comprehensive regulatory reforms in the cosmetics industry [1] - The meeting highlighted that the Chinese cosmetics market is projected to reach a total transaction value of 1,073.82 billion yuan in 2024, indicating continuous market expansion [1] - Despite the growth, the industry faces structural issues, with over 20,000 registered cosmetics companies but low market concentration and a lack of globally influential brands [1] Group 2: Clinical Innovations and Approvals - The first non-injection epinephrine product, Neffy® (优敏速®), has been approved in China for emergency treatment of severe allergic reactions, marking a significant milestone in drug innovation [4] - HaiXiang Pharmaceutical announced the initiation of Phase II clinical trials for NWRD06, a novel nucleic acid drug aimed at preventing liver cancer recurrence, which is the first of its kind targeting the GPC3 marker [5] - Xinhua Medical received registration for two types of medical devices, enhancing its competitiveness in the in vitro diagnostics market [6] Group 3: Financing and Market Expansion - Beijing Ruifeng Biotechnology completed a C-round financing of over 100 million yuan, aimed at expanding its commercial capabilities and enhancing research and development in both human and animal health [8][9] - Humatrix Medical announced the completion of an A+ round financing of over 100 million yuan, which will be used to advance clinical trials for its core product and expand its product pipeline [10] Group 4: Healthcare Insurance and Spending - The National Healthcare Security Administration reported that from January to November 2025, the total income of the basic medical insurance fund reached 2.632 trillion yuan, with total expenditures of 2.110 trillion yuan, indicating stable fund operations [12]

Core Viewpoint - The report highlights the changes in the Hong Kong Stock Connect holdings, indicating significant increases and decreases in ownership percentages for various companies, which may signal investment trends and market sentiment. Group 1: Increased Holdings - Zhejiang Shibao (01057) saw the largest increase in holdings, up by 2.33%, bringing the total to 57.54% [1][2] - Changfei Fiber Optic Cable (06869) experienced a 1.79% increase, with a new holding percentage of 58.13% [1][2] - Chalco International (02068) had a 1.19% increase, resulting in a holding percentage of 22.13% [1][2] - Other notable increases include Beijing Beichen Industrial (00588) and Junsheng Electronics (00699), both up by 1.03% [2] Group 2: Decreased Holdings - Shandong Molong (00568) faced the largest decrease, down by 1.38%, now holding 50.49% [1][2] - Zhaoyan New Drug (06127) saw a reduction of 1.22%, with a current holding of 56.82% [1][2] - Tianqi Lithium (09696) decreased by 1.01%, bringing its holding to 37.42% [1][2] - Other significant decreases include Jinyi Yongci (06680) and Zhongyuan Jianye (09982), down by 0.64% and 0.55% respectively [2] Group 3: Five-Day Changes - Over the last five trading days, Lion Holdings (02562) had the highest increase at 3.06%, with a holding of 46.20% [1][3] - Changfei Fiber Optic Cable (06869) increased by 2.58%, maintaining a holding of 58.13% [1][3] - Junsheng Electronics (00699) rose by 2.47%, now at 11.24% [1][3] - Conversely, Shandong Molong (00568) and Yihua Tong (02402) both decreased by 2.47% [1][3] Group 4: Twenty-Day Changes - Ji Hong Co. (02603) had the largest increase over twenty days, up by 21.54%, with a holding of 54.58% [1][4] - Lion Holdings (02562) also saw a significant increase of 21.40%, now at 46.20% [1][4] - Red Star Macalline (01528) increased by 8.04%, holding 51.70% [1][4]

Group 1 - The overall market trend before the Spring Festival is expected to have upward potential, with short-term opportunities for low-position layouts identified by Zhongtai Securities [9] - Daitong Securities indicates that the post-holiday market will be crucial, with a clear upward trend supported by loose monetary policy and strong performance in key sectors [9] - China Aviation Securities notes that the current domestic economic growth stabilization effects need further confirmation, suggesting a cautious approach in the current slow bull market, with potential for new highs in A-shares after new catalysts emerge [9] Group 2 - The U.S. stock market saw all three major indices decline, with the Dow Jones down 0.51%, Nasdaq down 0.50%, and S&P 500 down 0.35% [3] - Tesla shares fell by 3.2% as ARK Invest continued to reduce its holdings, selling $30 million worth of Tesla stock [3] - Major tech stocks showed mixed results, with Apple up 0.1% and Nvidia down 1.2%, while the Nasdaq China Golden Dragon Index fell by 0.67% [4] Group 3 - International oil prices increased, with WTI crude oil rising by 2.36% to $58.08 per barrel, and Brent crude oil up by 2.14% to $61.94 per barrel [5] - The precious metals market experienced significant declines, with COMEX gold futures dropping by 4.50% to $4325.10 per ounce, marking the largest drop in two months, and silver futures down 8.67% to $69.856 per ounce, the worst performance since February 2021 [5] Group 4 - The Ministry of Finance and the State Administration of Taxation announced that tobacco advertising expenses are not deductible for tax purposes, while advertising expenses for cosmetics, pharmaceuticals, and beverages can be deducted up to 30% of annual sales revenue [6] - From January to November, state-owned enterprises in China reported total operating revenue of 75,625.76 billion yuan, a year-on-year increase of 1.0%, while total profits decreased by 3.1% to 371.945 billion yuan [6]